Delivery Order SPE2DB20D9331-SPE2DB25FL1T4
Award Date 8/15/25
Potential Completion Date 9/8/25
Potential Value $148K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $148,084.30 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on July 17, 2025. The delivery order calls for 3,750 units of Asparlas (5 ML vials) with a completion date of August 7, 2025. This firm fixed-price contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its small business status. The award...
- The Defense Logistics Agency awarded a delivery order valued at $148,084.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas 5 milliliter vials. This firm fixed-price delivery order is expected to reach completion by August 29, 2025, and represents a continuation of the companies' ongoing pharmaceutical supply relationship. The award carries no set-aside designation, indicating that DMS...
- The Defense Logistics Agency awarded a delivery order valued at $118,467.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas 5 ml vials. The contract is firm fixed-price with an ultimate completion date of September 17, 2025. This delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion vehicle that...
- The Defense Logistics Agency awarded a delivery order valued at $148,084.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 3,750 units of Asparlas (5 ml vials). The contract is firm fixed-price with an ultimate completion date of September 23, 2025, and was awarded on September 2, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 3,750 units of Asparlas 5 mL vials. The contract, valued at $59,233.74, is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. This award was issued without set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $59,233.74 by the Defense Logistics Agency on September 10, 2025. The delivery order, with an ultimate completion date of October 1, 2025, calls for the supply of 3,750 units of Asparlas in 5 milliliter vials. This award was issued without a set-aside designation and represents a specific product delivery under DMS...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,614.78 fixed-price contract is for the delivery of 3,750 units of the drug Asparlas (5 mL vials) with a performance period through May 13, 2024. The award is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA, which allows the agency to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 31, 2025, with a ceiling value of $29,616.86 for the supply of 3,750 units of Asparlas 5 ML vials. Asparlas is a leukemia treatment medication, and this delivery order will be fulfilled from DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and valid through November...
- On August 21, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $59,233.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order calls for 3,750 units of Asparlas (5 mL vials) to be delivered by September 12, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. Asparlas is a pediatric acute lymphoblastic...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty-two thousand five hundred ninety-nine dollars and sixty cents ($52,599.60) by the Defense Logistics Agency to supply 3,750 units of the pharmaceutical product ASPARLAS 3,750 UNIT/5 ML VIAL 5ML. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to...